# Rifampin

NDC: 0143-9230
Generic name: Rifampin
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20160303

FDA application: ANDA205039

## Active ingredients

- RIFAMPIN: 600 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9230"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9230
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb59a48c-f66b-4ea0-809c-de0e4be2f8c2